Opioids Market Outlook 2025: Opportunities and Emerging Challenges

 Unlock 20% Off Global Market Reports Using Code ONLINE20 — Stay Informed on Trade Policies, Market Growth, and Key Disruptors

 

 How Is the Opioids Market Growth Forecast from 2025 to 2029?
 The opioids market size has grown marginally in recent years. It will grow from $23.54 billion in 2024 to $23.98 billion in 2025 at a compound annual growth rate (CAGR) of 1.9%. The growth in the historic period can be attributed to pain management, surgical procedures, palliative care, regulatory environment.
 
 The opioids market size is expected to see steady growth in the next few years. It will grow to $27.25 billion in 2029 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to non-cancer pain indications, regulatory changes, telemedicine and remote prescribing, chronic pain management. Major trends in the forecast period include opioid-sparing strategies, medication-assisted treatment (mat), risk mitigation, public health initiatives.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp
 
 Which Major Growth Factors Are Shaping the Opioids Market?
 Rising surgical procedures are expected to propel the growth of the opioids market going forward. Surgical procedures are defined as medical treatments that involve making an incision with tools, typically done in an operating room and typically requiring anesthetic or breathing support. Opioids are used during surgical procedures for treating pain and as anesthesia adjuncts or primary anesthetic agents. For instance, in August 2023, Organization for Economic Co-operation and Development, a France-based intergovernmental organization, the total number of cataract surgical procedures performed in the Czech Republic increased by 8.4% from 131,612 procedures in 2021 to 142,670 procedures in 2022. Further, the total number of laparoscopic repairs of inguinal hernia surgical procedures performed in Turkey increased by 35.2% from 18,739 in 2021 to 25,348 in 2022. Therefore, the rising number of surgical procedures will drive the opioid market.
 
 Which Segment Offers the Highest Growth Opportunities in the Opioids Market?
 The opioids market covered in this report is segmented — 
 
 1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types
 2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist
 3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain
 4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies
 5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment
 
 Subsegments:
 1) By Methadone: Methadone Tablets, Methadone Oral Solution
 2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations
 3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets
 4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations
 5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules
 6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations
 7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products
 
 How Are Innovation and Technology Shaping the Future Trends of the Opioids Market?
 Major companies operating in the opioid market are focused on innovating advanced drug solutions to intensify their position. The discovery of new medications can treat diseases and improve healthcare and scientific knowledge. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a US-based provider of solutions for treating opioid addiction, stated that the US Food and Drug Administration authorized Brixadi (buprenorphine) extended-release injectable for subcutaneous utilize (beneath the skin) for the treatment of direct to extreme opioid utilize clutter (OUD). It is the primary and sole week-after-week and month-to-month subcutaneous infusion for direct to serious OUD and the primary buprenorphine injectable using FluidCrystal Injection Depot Technology. Patients who receive oral buprenorphine-containing medications can be transitioned to equal dosages if the prescription advice is followed.
 
 Who Are the Key Players Driving the Opioids Market?
 Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.
 
 Get the full opioids market report here:
 https://www.thebusinessresearchcompany.com/report/opioids-global-market-report
 
 What Are the Regional Insights for the Opioids Market Forecast?
 North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company